Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05838235

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome

This research study aims to evaluate the effect of a 6-month adapted physical activity program (APA) on the endurance capacities (evaluated as the maximum oxygen consumption [VO2 peak] on a cardiopulmonary exercise test) of children and adolescents with Marfan syndrome or related.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Marfan syndrome (MFS) is characterized by the association of multisystem damage related to connective tissue fragility. The risk of aortic dissection has diverted attention from significant musculoskeletal damage despite commonly reported extreme fatigue and pain with impact on the patient's quality of life. In a recent study (Marfanpower, NCT03236571), investigators have observed reduced endurance capacities in children and teenagers with MFS (average VO2 peak at 60% of expected), which were significantly increased by an intensive rehabilitation program. Based on this experience, investigators aim to evaluate the effect of a physical activity program adapted to the daily life of the young patients on their endurance capacities and their quality of life. This program will be set up by an adapted physical activity (APA) coach after a complete assessment, including a cardiopulmonary exercise test with VO2 peak measurement, which will be carried out in the Reference Centre for Marfan syndrome at the Toulouse University Hospital. The VO2 peak evolution will be evaluated after 6 months of program. This is a recognized parameter for the evaluation of endurance and has been validated in children. Investigators hypothesize that the implementation of a physical activity program adapted to the daily life and interests of the child with MFS will efficiently improve endurance, prevent deconditioning and promote long term benefits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Genetically confirmed Marfan syndrome or related syndrome
  • Girl or boy aged 7 to 17
  • Informed and written consent signed by at least one of the two holders of parental authority
  • Patient affiliated to a social security scheme or equivalent

Exclusion criteria

  • Cardiac contraindications to the APA program:
  • Severe aortic dilation (aortic diameter > 45 mm)
  • and/or left ventricular failure (left ventricular ejection fraction <45%)
  • and/or severe mitral leakage ≥ grade 3
  • Pregnancy

Treatment and study plan

Adapted Physical Activity program

Other

The Adaptated Physical Activity program will consist of a Personalized Training Program

Primary outcomes

  1. Measurement of maximum endurance

    Time frame: At baseline

    maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured

  2. Measurement of maximum endurance

    Time frame: Up to 6 month

    maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured

Study contacts

Contact information is provided by the study sponsor or research team.

Fernanda BAJANCA

CONTACT

[email protected]

Thomas EDOUARD, MD

CONTACT

[email protected]

05 34 54 91 95

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Marfan&Moves (M&M's) : an Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome: an Interventional, Prospective, Monocentric Study.

Acronym: M&M's

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
May 1, 2023
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.